The present work aims to develop optimized scaffolds for bone repair by incorporating mesoporous nanoparticles into them, thereby combining bioactive factors for cell growth and preventing rapid release or loss of effectiveness. We synthesized biocompatible and biodegradable scaffolds designed for the controlled codelivery of curcumin (CUR) and recombinant human bone morphogenic protein-2 (rhBMP-2). Active agents in dendritic silica/titania mesoporous nanoparticles (DSTNs) were incorporated at different weight percentages (0, 2, 5, 7, 9, and 10 wt %) into a matrix of polycaprolactone (PCL) and polyethylene glycol (PEG) nanofibers, forming the CUR-BMP-2@DSTNs/PCL-PEG delivery system (S0, S2, S5, S7, S9, and S10, respectively, with the number showing the weight percentage). To enhance the formation process, the system was treated using low-intensity pulsed ultrasound (LIPUS). Different advanced methods were employed to assess the physical, chemical, and mechanical characteristics of the fabricated scaffolds, all confirming that incorporating the nanoparticles improves their mechanical and structural properties. Their hydrophilicity increased by approximately 25%, leading to ca. 53% enhancement in their water absorption capacity. Furthermore, we observed a sustained release of approximately 97% for CUR and 70% for BMP-2 for the S7 (scaffold with 7 wt % DSTNs) over 28 days, which was further enhanced using ultrasound. In vitro studies demonstrated accelerated scaffold biodegradation, with the highest level observed in S7 scaffolds, approximately three times higher than the control group. Moreover, the cell viability and proliferation on DSTNs-containing scaffolds increased when compared to the control group. Overall, our study presents a promising nanocomposite scaffold design with notable improvements in structural, mechanical, and biological properties compared to the control group, along with controlled and sustained drug release capabilities. This makes the scaffold a compelling candidate for advanced bone tissue engineering and regenerative therapies.

Proton exchange membranes (PEMs) are critical to fuel cell performance, where ion transport, catalyst activity, and mass transfer determine efficiency and durability. However, conventional membranes in PEM fuel cells often suffer from hydrogen crossover, limited conductivity, and poor interfacial stability. To address these challenges, this study develops a nanofiber membrane system with synergistic structural and interfacial enhancement. Through nanofiber architecture and surface engineering, the membrane balances proton conductivity, mechanical strength and electrochemical performance. The sandwich-structure nanofiber membrane (SSNFM) achieves a peak power density of 942 mW cm ⁻² after 100-hour accelerated stress testing, substantially outperforming conventional commercial membranes (520 mW cm ⁻² ). Electrochemical characterization confirms enhanced proton conductivity for SSNFM (40.4 mS cm ⁻¹ ) compared to commercial membranes (17.5 mS cm ⁻¹ ). Multiscale analyses, including x-ray computed tomography and multiphase simulations, reveal improved membrane properties, catalyst layer stability, and triple-phase boundary formation, facilitating efficient charge and mass transport. This work presents a membrane design strategy to enhance fuel cell performance in sustainable energy applications.

Electrospun fibres have emerged as vital components in developing tissue engineering scaffolds. Calcium phosphate-based materials, renowned for their bioactivity and biocompatibility, have garnered considerable attention in biomedical applications. This study focuses on the incorporation of amorphous calcium phosphate (ACP) nanoparticles into poly(L-lactic acid) (PLLA) to produce electrospun PLLA/ACP fibrous membranes. Subsequent treatment with acetone yielded a hierarchical porous structure, boasting an ultra-high surface area of 94.7753 ± 0.3884 m²/g. The ACP nanoparticles, initially encapsulated by PLLA, were exposed on the fibre surface after acetone treatment. Furthermore, the porous PLLA/ACP fibrous membrane exhibited superior mechanical properties (Young's modulus = 0.148 GPa, tensile strength = 3.05 MPa) and enhanced wettability. In a 7-day in vitro cell culture with human osteoblast-like cells, the porous PLLA/ACP fibrous membrane demonstrated a significant improvement in osteoblast adhesion and proliferation, with a proliferation rate increase of 252.0% and 298.7% at day 4 and day 7, respectively. These findings underscore the potential of the porous PLLA/ACP fibrous membrane as a promising candidate for bone tissue scaffolds.

Fibres play a crucial role in diverse biomedical applications, ranging from tissue engineering to drug delivery. Electrospinning has emerged as a simple and versatile technique for producing ultrafine fibres at micro- to nanoscale dimensions. Synthetic biopolymers are effective cues to replace damaged tissue in the biomedical field, both in vitro and in vivo applications. Among them, poly (L-lactic acid) (PLLA) is a renewable, environmentally friendly biopolymer material. Polycaprolactone (PCL) is a synthetic polymer with good biocompatibility and biodegradation characteristics. However, both electrospun PLLA and PCL fibres have their limitations. To overcome these shortcomings, electrospinning PLLA/PCL blend fibres has been the subject of many studies. This review discusses the different parameters for the electrospinning of PLLA/PCL-based fibres for biomedical applications. Furthermore, we also discuss how electrospun PLLA/PCL-based scaffolds can be modified or combined with other biomaterials, such as natural polymers and bioceramics, and examine their in vitro and in vivo applications in various tissue repair strategies.